Under post marketing studier med andre vacciner indeholdende hepatitis B, blev serum syge lignende sygdom og trombocytopeni rapporteret meget sjældent.
During post marketing surveillance studies with other hepatitis B containing vaccines, serum sickness like disease and thrombocytopenia have been reported very rarely.